Allergic contact dermatitis from apraclonidine

被引：6

作者：

Armisen, M

Vidal, C

Quintans, R

Suarez, A

Castroviejo, M

机构：

[1] Univ Santiago de Compostela, Hosp Conxo, Allergy Unit, Santiago De Compostela 15706, Spain

[2] Univ Santiago de Compostela, Hosp Conxo, Serv Ophthalmol, Santiago De Compostela 15706, Spain

来源：

CONTACT DERMATITIS | 1998年 / 39卷 / 04期

关键词：

allergic contact dermatitis; glaucoma; apraclonidine hydrochloride; medicaments; ophthalmics; autoxidation;

D O I：

10.1111/j.1600-0536.1998.tb05893.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：193 / 193

页数：1

共 5 条

[1] CLINICAL-EXPERIENCE WITH THE LONG-TERM USE OF 1-PERCENT APRACLONIDINE - INCIDENCE OF ALLERGIC REACTIONS [J].

BUTLER, P ;

MANNSCHRECK, M ;

LIN, S ;

HWANG, I ;

ALVARADO, J .

ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (03) :293-296

[2]

Gross RL, 1997, J GLAUCOMA, V6, P298

[3]

NAGASUBRAMANIAN S, 1993, OPHTHALMOLOGY, V100, P1318

[4] Mechanisms of adrenergic agonist induced allergy bioactivation and antigen formation [J].

Thompson, CD ;

MacDonald, TL ;

Garst, ME ;

Wiese, A ;

Munk, SA .

EXPERIMENTAL EYE RESEARCH, 1997, 64 (05) :767-773

[5] A proposed mechanism for p-aminoclonidine allergenicity based on its relative oxidative lability [J].

Thompson, CD ;

Vachaspati, PR ;

Kolis, SP ;

Gulden, PH ;

Garst, ME ;

Wiese, A ;

Munk, SA ;

Harman, WD ;

Macdonald, TL .

CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (09) :1032-1036

← 1 →